In addition, Qu et al. reported that cancer-associated fibroblast-derived exosomal DACT3-AS1 promotes tumorigenesis and oxaliplatin resistance in gastric cancer by targeting the miR-181a-5p/SIRT1 axis [16]. This evidence concerns the gene DACT3 and gastric cancer.